Antepartum Summary
0.0.1-current - ci-build

Antepartum Summary, published by IHE Patient Care Coordination Committee. This is not an authorized publication; it is the continuous build for version 0.0.1-current). This version is based on the current content of https://github.com/IHE/PCC.APS/ and changes regularly. See the Directory of published versions

## ValueSet: Antepartum Laboratory

Official URL: https://profiles.ihe.net/PCC/APS/ValueSet/Antepartum.Laboratory.VS | Version: 0.0.1-current
Draft as of 2023-10-24 | Computable Name: Antepartum_Laboratory_VS

TBD

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

### Logical Definition (CLD)

- Include these codes as defined in `http://loinc.org`

  Code | Display
  890-4 | Ab Screen
  883-9 | ABO Group
  10331-7 | Rh
  5196-1 | HBV surface Ag (EIA)
  5195-3 | HBV surface Ag
  5197-9 | HBV surface Ag (RIA)
  7905-3 | HBV surface Ag (Neut)
  718-7 | Hgb
  4544-3 | Hct (Automated count)
  30350-3 | Hgb
  13514-5 | Hemoglobin pattern [interpretation] in Blood by Electrophoresis Narrative
  21440-3 | HPV I/H Risk DNA Cervix (Probe)
  21441-1 | HPV Low Risk DNA Cervix (Probe)
  10524-7 | Cytology Cervix
  18500-9 | Thin Prep Cervix
  19765-7 | Cytology Cervix/Vaginal (Nominal)
  19766-5 | Cytology Cervix/Vaginal (Narrative)
  5334-8 | RUBV Ab IgG (EIA)
  20458-6 | RUBV Ab IgG
  40667-8 | RUBV Ab IgG (EIA)
  8014-3 | RUBV Ab IgG
  1647-7 | Purified protein derivative skin test
  6347-9 | Chlamydia Ag
  14510-2 | Chlamydia trachomatis Ag (Vaginal)
  14474-1 | Chlamydia trachomatis Ag (Urine)
  6349-5 | Chlamydia trachomatis (Unspecified specimen)
  691-6 | Neisseria Gonorrhoeae (genital specimen)
  9568-7 | Neisseria Gonorrhoeaea Ab
  45067-6 | Chlamydia Trachomatis Neisseria Gonorrhoeae (Cervix)
  45074-2 | Chlamydia Trachomatis Neisseria Gonorrhoeae (Urine)
  35096-7 | OB Ultrasound Panel
  30525-0 | Age
  29463-7 | Body Weight
  18185-9 | Gestational Age
  20450-3 | Alpha-1-Fetoprotein
  48803-1 | Neural Tube Defect Risk
  33774-1 | Karotype
  33773-3 | Karyotype (Amino Fluid)
  41273-4 | Alpha-1-Fetoprotein, Amniotic Fluid Semi-Quantitative
  1832-5 | Alpha-1-Fetoprotein [Multiple of the median] in Amniotic Fluid
  29595-6 | Alpha-1-Fetoprotein [Mass/volume] in Amniotic Fluid
  1557-8 | Fasting Blood Glucose-Venous
  14770-2 | Fasting Blood Glucose-Capillary
  1507-3 | Glucose 1HR post 75 g glucose
  14995-5 | Glucose 2HR post 75 g glucose
  20437-0 | Glucose 3HR post 75 g glucose
  31147-2 | Reagin Ab
  20508-8 | Reagin Ab by RPR
  5292-8 | Reagin Ab by VDRL
  48683-7 | Beta Strep Group B (PCR)
  11267-2 | Strep Group B
  21198-7 | Beta HCG
  15410-4 | Varicella zoster virus Ab.IgG (EIA)
  17763-4 | Varicella zoster virus Ab.IgG (IF)
  20465-1 | Choriogonadotropin/Choriogonatotropin, Control Serum Quantitative
  20466-9 | Estriol/Estriol, Control Serum Quantitative
  20406-5 | Glucose
  20505-4 | Bilirubin
  5797-6 | Ketones
  5811-5 | Specific Gravity
  5803-2 | pH
  5804-0 | Protein
  20405-7 | Urobilinogen
  20407-3 | Nitrite
  5794-3 | Hemoglobin
  5799-2 | Leukocyte esterase
  5767-9 | Appearance
  5778-6 | Color
  9842-6 | Casts
  5787-7 | Epithelial cells
  13945-1 | Erythrocytes
  5769-5 | Bacteria
  49588-7 | First trimester maternal screen with nuchal translucency [interpretation] Narrative
  11580-8 | Thyrotropin (3rd generation)
  3016-3 | TSH
  5385-0 | Thyrotropin Receptor Ab
  27975-2 | TSH (serum)
  3051-0 | T3 Free
  3052-8 | T3 Reverse
  3054-4 | T3 True
  3050-2 | T3 Resin Uptake

### Expansion

This value set contains 81 concepts

Expansion based on:

- Loinc v2.74
- Loinc v2.74

Code | System | Display
890-4 | http://loinc.org | Ab Screen
883-9 | http://loinc.org | ABO Group
10331-7 | http://loinc.org | Rh
5196-1 | http://loinc.org | HBV surface Ag (EIA)
5195-3 | http://loinc.org | HBV surface Ag
5197-9 | http://loinc.org | HBV surface Ag (RIA)
7905-3 | http://loinc.org | HBV surface Ag (Neut)
718-7 | http://loinc.org | Hgb
4544-3 | http://loinc.org | Hct (Automated count)
30350-3 | http://loinc.org | Hgb
13514-5 | http://loinc.org | Hemoglobin pattern [interpretation] in Blood by Electrophoresis Narrative
21440-3 | http://loinc.org | HPV I/H Risk DNA Cervix (Probe)
21441-1 | http://loinc.org | HPV Low Risk DNA Cervix (Probe)
10524-7 | http://loinc.org | Cytology Cervix
18500-9 | http://loinc.org | Thin Prep Cervix
19765-7 | http://loinc.org | Cytology Cervix/Vaginal (Nominal)
19766-5 | http://loinc.org | Cytology Cervix/Vaginal (Narrative)
5334-8 | http://loinc.org | RUBV Ab IgG (EIA)
20458-6 | http://loinc.org | RUBV Ab IgG
40667-8 | http://loinc.org | RUBV Ab IgG (EIA)
8014-3 | http://loinc.org | RUBV Ab IgG
1647-7 | http://loinc.org | Purified protein derivative skin test
6347-9 | http://loinc.org | Chlamydia Ag
14510-2 | http://loinc.org | Chlamydia trachomatis Ag (Vaginal)
14474-1 | http://loinc.org | Chlamydia trachomatis Ag (Urine)
6349-5 | http://loinc.org | Chlamydia trachomatis (Unspecified specimen)
691-6 | http://loinc.org | Neisseria Gonorrhoeae (genital specimen)
9568-7 | http://loinc.org | Neisseria Gonorrhoeaea Ab
45067-6 | http://loinc.org | Chlamydia Trachomatis Neisseria Gonorrhoeae (Cervix)
45074-2 | http://loinc.org | Chlamydia Trachomatis Neisseria Gonorrhoeae (Urine)
35096-7 | http://loinc.org | OB Ultrasound Panel
30525-0 | http://loinc.org | Age
29463-7 | http://loinc.org | Body Weight
18185-9 | http://loinc.org | Gestational Age
20450-3 | http://loinc.org | Alpha-1-Fetoprotein
48803-1 | http://loinc.org | Neural Tube Defect Risk
33774-1 | http://loinc.org | Karotype
33773-3 | http://loinc.org | Karyotype (Amino Fluid)
41273-4 | http://loinc.org | Alpha-1-Fetoprotein, Amniotic Fluid Semi-Quantitative
1832-5 | http://loinc.org | Alpha-1-Fetoprotein [Multiple of the median] in Amniotic Fluid
29595-6 | http://loinc.org | Alpha-1-Fetoprotein [Mass/volume] in Amniotic Fluid
1557-8 | http://loinc.org | Fasting Blood Glucose-Venous
14770-2 | http://loinc.org | Fasting Blood Glucose-Capillary
1507-3 | http://loinc.org | Glucose 1HR post 75 g glucose
14995-5 | http://loinc.org | Glucose 2HR post 75 g glucose
20437-0 | http://loinc.org | Glucose 3HR post 75 g glucose
31147-2 | http://loinc.org | Reagin Ab
20508-8 | http://loinc.org | Reagin Ab by RPR
5292-8 | http://loinc.org | Reagin Ab by VDRL
48683-7 | http://loinc.org | Beta Strep Group B (PCR)
11267-2 | http://loinc.org | Strep Group B
21198-7 | http://loinc.org | Beta HCG
15410-4 | http://loinc.org | Varicella zoster virus Ab.IgG (EIA)
17763-4 | http://loinc.org | Varicella zoster virus Ab.IgG (IF)
20465-1 | http://loinc.org | Choriogonadotropin/Choriogonatotropin, Control Serum Quantitative
20466-9 | http://loinc.org | Estriol/Estriol, Control Serum Quantitative
20406-5 | http://loinc.org | Glucose
20505-4 | http://loinc.org | Bilirubin
5797-6 | http://loinc.org | Ketones
5811-5 | http://loinc.org | Specific Gravity
5803-2 | http://loinc.org | pH
5804-0 | http://loinc.org | Protein
20405-7 | http://loinc.org | Urobilinogen
20407-3 | http://loinc.org | Nitrite
5794-3 | http://loinc.org | Hemoglobin
5799-2 | http://loinc.org | Leukocyte esterase
5767-9 | http://loinc.org | Appearance
5778-6 | http://loinc.org | Color
9842-6 | http://loinc.org | Casts
5787-7 | http://loinc.org | Epithelial cells
13945-1 | http://loinc.org | Erythrocytes
5769-5 | http://loinc.org | Bacteria
49588-7 | http://loinc.org | First trimester maternal screen with nuchal translucency [interpretation] Narrative
11580-8 | http://loinc.org | Thyrotropin (3rd generation)
3016-3 | http://loinc.org | TSH
5385-0 | http://loinc.org | Thyrotropin Receptor Ab
27975-2 | http://loinc.org | TSH (serum)
3051-0 | http://loinc.org | T3 Free
3052-8 | http://loinc.org | T3 Reverse
3054-4 | http://loinc.org | T3 True
3050-2 | http://loinc.org | T3 Resin Uptake

Explanation of the columns that may appear on this page:

Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System | The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code | The code (used as the code in the resource instance)
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition | An explanation of the meaning of the concept
Comments | Additional notes about how to use the code